当前位置: 首页 > 期刊 > 《医药产业资讯》 > 2012年第23期 > 正文
编号:12273812
microRNA-34a与非小细胞肺癌的关系及其可能调节机制(3)
http://www.100md.com 2012年8月15日 曾婷 郝丽 谢逸欣 马丽 舒文杰
第1页

    参见附件。

     总之,本次研究发现miRNA-34a对肺癌的发生具有一定的调节作用,可能是肺癌发生的重要环节,miRNA-34a主要是通过与c-myc的结合而发挥其调节作用。

    [参考文献]

    [1] 张风林.血管内皮生长因子受体和AQP1在非非小细胞肺癌中的表达[J].中国现代医学杂志,2012,22(4):65-69.

    [2] 陈衍,韩晟,薛妍,等.274例非非小细胞肺癌临床特点分析[J].实用临床医药杂志,2012,16(1): 36-38.

    [3] Lefebvre CW,Hoekstra J. Approach to non-ST-segment elevation acute coronary syndrome in the emergency department:risk stratification and treatment strategies [J]. Hosp Pract (Minneap),2010,38(2):40-49.

    [4] 孙秀锦,黄铖铖,涂彧,等.miR-34a在辐射损伤时对细胞周期的调控作用[J].苏州大学学报:医学版,2011,31(3):350-353.

    [5] Chen Y,Zhu X,Zhang X,et al. Nanoparticles modified with tumor-targeting scFv deliver siRNA and miRNA for cancer therapy [J]. Mol Ther,2010,18(9): 1650-1656.

    [6] Bommer GT,Gerin I,Feng Y,et al. p53-mediated activation of miRNA34 candidate tumor-suppressor genes [J]. Curr Biol,2007,17(15):1298-1307.

    [7] Song N,Tan W,Xing D,et al. CYP 1A1 polymorphism and risk of lung cancer in relation to tobacco smoking:a case-control study in China [J]. Carcinogenesis,2001,22(1):11-16.

    [8] Gervasini G,San JC,Carrillo JA,et al. GST polymorphisms interact with dietary factors to modulate lung cancer risk:study in a high-incidence area [J]. Nutr Cancer,2010,62(6):750-758.

    [9] Kato A,Shimizu K,Shimoichi Y,et al. Aberrant DNA methylation of E-cadherin and p16 genes in rat lung adenocarcinomas induced by N-nitrosobis(2-hydroxypropyl)amine [J]. Mol Carcinog,2006,45(2):106-111.

    [10] Georgiou E,Valeri R,Tzimagiorgis G,et al. Aberrant p16 promoter methylation among Greek lung cancer patients and smokers: correlation with smoking [J]. Eur J Cancer Prev,2007,16(5):396-402.

    (收稿日期:2012-05-14 本文编辑:程 铭)

您现在查看是摘要介绍页,详见PDF附件(2901kb)